ROMY 250MCG INJECTION

Romy 250mcg Injection is a romiplostim-based formulation used for the treatment of chronic immune thrombocytopenia (ITP). It helps increase platelet production in patients who have low platelet counts due to immune-related conditions. By stimulating the bone marrow, Romy 250 mcg Injection supports the body’s natural ability to maintain healthy platelet levels and reduce the risk of bleeding complications.

This injection works as a thrombopoietin receptor agonist, encouraging the production of platelets in patients who do not respond adequately to other therapies. Romy 250 mcg Injection is commonly prescribed when corticosteroids, immunoglobulins, or splenectomy have not provided sufficient improvement. When administered under medical supervision, it helps maintain stable platelet counts and improves overall treatment outcomes.

Romy 250 mcg Injection is widely used in hospital and specialty care settings where consistent quality and safety standards are essential. Proper storage and handling ensure maximum potency and effectiveness. It is one of the trusted products in the pharmaceutical sector for platelet management and immune-related hematological conditions.

Product Features

• Contains Romiplostim 250 mcg formulation
• Used for chronic immune thrombocytopenia (ITP)
• Stimulates platelet production in bone marrow
• Helps reduce bleeding risk
• Administered under strict medical supervision

How It Helps

• Increases platelet count effectively
• Reduces risk of bruising and bleeding
• Supports long-term platelet management
• Improves overall quality of life in ITP patients